Side-chain and backbone amide bond requirements for glycopeptide stimulation of T-cells obtained in a mouse model for rheumatoid arthritis

被引:17
作者
Holm, Lotta
Bockermann, Robert
Wellner, Erik
Baecklund, Johan
Holmdahl, Rikard
Kihlberg, Jan [1 ]
机构
[1] Umea Univ, Dept Chem, SE-90187 Umea, Sweden
[2] Lund Univ, Sect Med Inflammat Res, SE-22184 Lund, Sweden
[3] AstraZeneca R&D Molndal, SE-43183 Molndal, Sweden
关键词
glycopeptide; collagen; T-cell; rheumatoid arthritis; amide bond isostere; peptide mimetics;
D O I
10.1016/j.bmc.2006.05.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Collagen induced arthritis (CIA) is the most studied animal model for rheumatoid arthritis and is associated with the MHC class II molecule A(q). T-cell recognition of a peptide from type II collagen, C11256-270, bound to A(q) is a requirement for development of CIA. Lysine 264 is the major T-cell recognition site of C11256-270 and CIA is in particular associated with recognition of lysine 264 after posttranslational hydroxylation and subsequent attachment of a beta-D-galactopyranosyl moiety. In this paper we have studied the structural requirements of collagenous glycopeptides required for T-cell stimulation, as an extension of earlier studies of the recognition of the galactose moiety. Synthesis and evaluation of alanine substituted glycopeptides revealed that there are T-cells that only recognise the galactosylated hydroxylysine 264, and no other amino acid side chains in the peptide. Other T-cells also require glutamic acid 266 as a T-cell contact point. Introduction of a methylene ether isostere instead of the amide bond between residues 260 and 261 allowed weaker recognition by some, but not all, of the T-cells. Altogether, these results allowed us to propose a model for glycopeptide recognition by the T-cells, where recognition from one or the other side of the galactose moiety could explain the different binding patterns of the T-cells. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5921 / 5932
页数:12
相关论文
共 61 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   ALTERED REACTIVITY IN MIXED LYMPHOCYTE CULTURE OF LYMPHOCYTES FROM PATIENTS WITH RHEUMATOID ARTHRITIS [J].
ASTORGA, GP ;
WILLIAMS, RC .
ARTHRITIS AND RHEUMATISM, 1969, 12 (06) :547-&
[3]  
Bäcklund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO
[4]  
2-A
[5]   Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis [J].
Bäcklund, J ;
Carlsen, S ;
Höger, T ;
Holm, B ;
Fugger, L ;
Kihlberg, J ;
Burkhardt, H ;
Holmdahl, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9960-9965
[6]   A FAST PROCEDURE FOR THE REDUCTION OF AZIDES AND NITRO-COMPOUNDS BASED ON THE REDUCING ABILITY OF SN(SR)3-SPECIES [J].
BARTRA, M ;
ROMEA, P ;
URPI, F ;
VILARRASA, J .
TETRAHEDRON, 1990, 46 (02) :587-594
[7]  
BRAND DD, 1994, J IMMUNOL, V152, P3088
[8]   T cells recognize a glycopeptide derived from type II collagen in a model for rheumatoid arthritis [J].
Broddefalk, J ;
Bäcklund, J ;
Almqvist, F ;
Johansson, M ;
Holmdahl, R ;
Kihlberg, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (31) :7676-7683
[9]   Preparation of a diglycosylated hydroxylysine building block used in solid-phase synthesis of a glycopeptide from type II collagen [J].
Broddefalk, J ;
Forsgren, M ;
Sethson, I ;
Kihlberg, J .
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (24) :8948-8953
[10]   EXPRESSION OF A TRANSGENIC CLASS-II AB GENE CONFERS SUSCEPTIBILITY TO COLLAGEN-INDUCED ARTHRITIS [J].
BRUNSBERG, U ;
GUSTAFSSON, K ;
JANSSON, L ;
MICHAELSSON, E ;
AHRLUND-RICHTER, L ;
PETTERSSON, S ;
MATTSSON, R ;
HOLMDAHL, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) :1698-1702